Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by Infinium Global Research on diabetes devices and drugs market provides in-depth analysis of segments and sub-segments in the global as well as regional diabetes devices and drugs market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional diabetes devices and drugs market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global diabetes devices and drugs market.
The diabetic devices and medications market is the segment of the healthcare industry that focuses on the development, manufacturing, and distribution of pharmaceuticals and medical devices that are specially designed for the management and treatment of diabetes. This market includes a wide variety of products such as insulin pumps, injectable pharmaceuticals intended to control blood sugar levels, insulin pens, continuous glucose monitoring, and oral treatments. Due to constant innovation to provide patients with more sophisticated, user-friendly, and efficient solutions, this market has grown significantly due to the increasing global prevalence of diabetes. It's a profitable industry where businesses compete to provide innovative tools and drugs to meet the demands of people with diabetes, simultaneously aiming for greater health and a higher standard of living.
The growing global prevalence of diabetes significantly drives market growth. More efficient, practical, and easily accessible tools and medications are needed to manage diabetes as the number of people with the disease keeps rising. An aging population, unhealthy dietary habits, sedentary lifestyle, and changing habits all contribute to this demand. The requirement for improved diabetes management solutions, including enhanced drug therapies, sophisticated insulin delivery systems, and non-invasive monitoring devices, is driving the development and commercial success of products in this market. Additionally, an increase in product approvals and launches is expected to drive the anticipated expansion of the global market for diabetic medications and devices. For instance, in December 2022, Dexcom, Inc., a firm specializing in the development, manufacturing, production, and distribution of continuous glucose monitoring systems for diabetes management, approved the receipt of U.S. Food and Drug Administration (FDA) clearance for its advanced DexcomG7 Continuous Glucose Monitoring (CGM) System. People with Type 1 and Type 2 diabetes who are two years of age or older can take this medication. However, the diabetes devices and drugs market faces stringent regulatory hurdles and compliance requirements that hamper the growth of the market. Furthermore, the continuous advancements in genetics, biomarkers, and data analytics create lucrative market growth opportunities. These developments make it feasible to better understand patient reactions to different drugs on a deeper level.
North America holds the largest market share in the diabetic devices and drugs market. A strong healthcare system, cutting-edge technology advancements, and a high rate of diabetes cases in the area are reasons for this dominant position. The well-established pharmaceutical and medical device businesses in North America also contribute significantly to the market's supremacy, consistently developing and introducing cutting-edge solutions for diabetes management. Furthermore, North America maintains its lead in this competitive market segment owing to a considerable focus on research and development, coupled with a strong consumer base seeking effective diabetic care. Moreover, the Asia Pacific emerged as the fastest-growing region in the diabetes devices and drugs market. The utilization of diabetes management techniques and pharmaceuticals is rising significantly across Asia Pacific due to increasing healthcare awareness and access to high-quality medical resources. This rapid growth can be attributed to several factors, notably the growing awareness and implementation of diabetic devices and drugs. Additionally, demographic changes and lifestyle shifts have led to a higher incidence of diabetes in the region, further propelling the demand for effective solutions. Businesses entering this market stand for growth unleash their creative potential, and thrive by meeting the diverse needs of the region's growing customer base.
| Report Coverage | Details |
|---|---|
| Market Size in 2022 | USD 159.1 Billion |
| Market Size by 2030 | USD 383.6 Billion |
| Growth Rate from 2023 to 2030 | CAGR of 10.18% |
| Largest Market | North America |
| No. of Pages | 180 |
| Market Drivers |
|
| Market Segmentation | By Type, and By End User |
| Regional Scope | North America, Europe, Asia Pacific, and RoW |
The report on global diabetes devices and drugs market provides a detailed analysis of segments in the market based on Type, and End User.
· Devices
· Drugs
· Hospitals
· Clinics
· Ambulatory Surgical Centers
· Home Care Centers
· Self-care
· Novo Nordisk A/S
· Ypsomed AG
· Abbott Laboratories
· Ascensia Diabetes Care Holdings AG
· Eli Lilly and Company
· Hoffmann-La Roche Ltd.
· Johnson & Johnson,Inc.
· Medtronic
· BD
· Terumo Corporation
The report provides deep insights into demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the diabetes devices and drugs market. Moreover, the study highlights current market trends and provides forecasts from 2023-2030. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.